Royce & Associates LP held its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 35,100 shares of the company’s stock at the end of the 2nd quarter. Royce & Associates LP owned 0.07% of Nu Skin Enterprises worth $2,206,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of the business. BlackRock Inc. raised its stake in Nu Skin Enterprises by 21,593.4% in the 1st quarter. BlackRock Inc. now owns 6,683,531 shares of the company’s stock worth $371,201,000 after purchasing an additional 6,652,722 shares in the last quarter. Vanguard Group Inc. raised its stake in Nu Skin Enterprises by 11.8% in the 1st quarter. Vanguard Group Inc. now owns 6,011,632 shares of the company’s stock worth $333,887,000 after purchasing an additional 634,951 shares in the last quarter. Wellington Management Group LLP raised its stake in Nu Skin Enterprises by 7.3% in the 1st quarter. Wellington Management Group LLP now owns 1,944,383 shares of the company’s stock worth $107,991,000 after purchasing an additional 131,493 shares in the last quarter. Schroder Investment Management Group raised its stake in Nu Skin Enterprises by 139.4% in the 1st quarter. Schroder Investment Management Group now owns 1,711,619 shares of the company’s stock worth $94,687,000 after purchasing an additional 996,731 shares in the last quarter. Finally, State Street Corp raised its stake in Nu Skin Enterprises by 76.7% in the 1st quarter. State Street Corp now owns 1,416,873 shares of the company’s stock worth $78,695,000 after purchasing an additional 614,817 shares in the last quarter. Institutional investors and hedge funds own 79.25% of the company’s stock.
In other news, General Counsel D Matthew Dorny sold 8,250 shares of the stock in a transaction dated Wednesday, July 5th. The shares were sold at an average price of $62.92, for a total value of $519,090.00. Following the sale, the general counsel now directly owns 46,730 shares of the company’s stock, valued at $2,940,251.60. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Ryan S. Napierski sold 8,000 shares of the stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $65.00, for a total transaction of $520,000.00. Following the completion of the sale, the president now directly owns 68,170 shares in the company, valued at $4,431,050. The disclosure for this sale can be found here. Over the last three months, insiders sold 28,357 shares of company stock worth $1,783,535. Insiders own 5.20% of the company’s stock.
Nu Skin Enterprises, Inc. (NYSE:NUS) opened at 62.60 on Wednesday. The firm has a 50-day moving average of $60.64 and a 200 day moving average of $57.57. Nu Skin Enterprises, Inc. has a 12-month low of $46.35 and a 12-month high of $66.04. The company has a market capitalization of $3.31 billion, a price-to-earnings ratio of 20.94 and a beta of 1.37.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.08. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The firm had revenue of $550.10 million for the quarter, compared to the consensus estimate of $548.09 million. During the same period in the prior year, the firm posted $0.79 earnings per share. The company’s revenue for the quarter was down 8.4% on a year-over-year basis. Analysts expect that Nu Skin Enterprises, Inc. will post $3.23 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Stockholders of record on Friday, August 25th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date is Wednesday, August 23rd. Nu Skin Enterprises’s payout ratio is 48.81%.
NUS has been the subject of several analyst reports. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Deutsche Bank AG lifted their price objective on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the stock a “buy” rating in a research note on Wednesday, June 21st. Pivotal Research reiterated a “buy” rating and issued a $80.00 price objective (up previously from $65.00) on shares of Nu Skin Enterprises in a research note on Thursday, June 22nd. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Finally, Bank of America Corporation lifted their price objective on shares of Nu Skin Enterprises from $53.00 to $57.00 and gave the stock an “underperform” rating in a research note on Monday, July 10th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $62.88.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.